MedTrace Logo

Gabapentin for Relief of Immediate Postoperative Pain

NCT03750773 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2020-07-29

No results posted yet for this study

Summary

The purpose of this study is to use gabapentin as an additional or alternative treatment for short term pain control following cesarean delivery in order to reduce the use of opioid pain medication and improve overall pain control following surgery.

Conditions

  • Postoperative Pain

Interventions

DRUG

Gabapentin 600mg

Subject is given Gabapentin 600mg every 8 hours x 48 hours postoperatively for pain control.

DRUG

Placebo oral capsule

Subject is given a Placebo capsule every 8 hours x 48 hours postoperatively for pain control.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • David M Haas, MD, MS · IUSM, Dept OBGYN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-02
Primary Completion
2020-03-31
Completion
2020-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03750773 on ClinicalTrials.gov